Synthetic repertoires derived from convalescent COVID-19 patients enable discovery of SARS-CoV-2 neutralizing antibodies and a novel quaternary binding modality
Jule Goike, Ching-Lin Hsieh, Andrew Horton, Elizabeth C. Gardner, Foteini Bartzoka, Nianshuang Wang, Kamyab Javanmardi, Andrew Herbert, Shawn Abbassi, Rebecca Renberg, Michael J. Johanson, Jose A. Cardona, Thomas Segall-Shapiro, Ling Zhou, Ruth H. Nissly, Abhinay Gontu, Michelle Byrom, Andre C. Maranhao, Anna M. Battenhouse, Varun Gejji, Laura Soto-Sierra, Emma R. Foster, Susan L. Woodard, Zivko L. Nikolov, Jason Lavinder, Will N. Voss, Ankur Annapareddy, Gregory C. Ippolito, Andrew D. Ellington, Edward M. Marcotte, Ilya J. Finkelstein, Randall A. Hughes, James M. Musser, Suresh V. Kuchipudi, Vivek Kapur, George Georgiou, John M. Dye, Daniel R. Boutz, Jason S. McLellan, Jimmy D. Gollihar
bioRxiv 2021.04.07.438849; doi: https://doi.org/10.1101/2021.04.07.438849 New Results
